Reading Your Echocardiogram Report
At a Glance
An echocardiogram for rheumatic heart disease shows how valve scarring affects narrowing, leakage, pressure, heart pumping, and chamber size. Doctors interpret the mitral valve area, pressure gradient, lung-pressure estimate, rhythm, and clot testing together rather than relying on one number.
An echocardiogram (or “echo”) is an ultrasound of your heart that allows doctors to see exactly how rheumatic heart disease has changed the structure of your heart. In rheumatic disease, the immune system’s attack causes the valves to become thick, stiff, and scarred [1][2].
How Rheumatic Valves Change
The echo looks for a specific “look” that identifies rheumatic damage. As the valves try to heal from inflammation, they undergo three main changes:
- Thickening: The delicate, tissue-paper-thin leaflets of the valve become thick and bulky [1].
- Commissural Fusion: This is a hallmark of rheumatic disease. The “commissures” are the corners where the valve leaflets meet. In RHD, these corners scar and fuse together, making the opening smaller [2][1].
- Calcification: Over time, the scarred tissue can turn hard and “bony” due to calcium deposits, making the valve even less flexible [1][3].
While the mitral valve is the most commonly affected, rheumatic disease frequently affects the aortic valve and sometimes the tricuspid valve [4][5]. Your report should assess all four heart valves.
Understanding Your Echo Numbers
Your report will contain several measurements that determine how advanced your condition is. Doctors never use just one number to make a decision; they look at the whole picture.
1. Mitral Valve Area (MVA)
This is a measurement of the actual size of the valve opening. In a healthy heart, the mitral valve is quite large (4.0 to 6.0 cm²).
- Clinically Significant (Moderate-to-Severe): MVA ≤ 1.5 cm². This is often the threshold where doctors begin considering treatments closely [6].
- Severe Stenosis: Often defined as MVA ≤ 1.0 cm² [7].
- Note: MVA is not interpreted alone. Your doctor must weigh it against how much blood is flowing and your symptoms.
2. Transmitral Mean Gradient
This measures the “pressure drop” across the valve. Because the opening is narrow, the heart has to build up pressure to push blood through. A higher gradient usually means more severe narrowing. However, this number can fluctuate wildly based on your heart rate or if you are in atrial fibrillation during the test [8][9].
3. Pulmonary Artery Systolic Pressure (PASP)
When the mitral valve is blocked, pressure “backs up” into the blood vessels of your lungs. An echo PASP above 40 mmHg is an estimate that pulmonary pressures might be high [10][11]. However, this is just an estimate with technical limitations, not a definitive diagnosis. If your doctor suspects severe pulmonary hypertension, they may order a right-heart catheterization to confirm it.
Secondary Changes: The “Back-Up” Effect
The echo also looks at how the rest of your heart is reacting to the damaged valve.
- Ejection Fraction (EF): This measures how well the left ventricle pumps with each beat. A normal EF is usually 50% or higher.
- Left Atrial Dilation: Because blood gets stuck waiting to go through the mitral valve, the left atrium (the chamber above the valve) stretches out and becomes enlarged [12].
- Thrombus (Clot) Check: An enlarged left atrium is a high-risk area for blood clots. Crucially, a routine standard echo (transthoracic) cannot reliably see the left atrial appendage where most clots hide. Just because your routine echo doesn’t mention a clot does not mean one isn’t there [13]. Doctors often order a Transesophageal Echo (TEE)—an ultrasound down the throat—to definitively check for clots before a procedure.
Echo Report Completeness Checklist
A high-quality echo report for rheumatic heart disease should evaluate:
- Valve Anatomy: Detailed description of thickening, fusion, and calcification for all four valves [1].
- MVA Measurement & Regurgitation: How narrow the valve is (MVA) and grading of any leaking (mild/moderate/severe) [14].
- Mean Gradient: The average pressure difference across the valves [8].
- Chamber Sizes & Function: Measurements of the left atrium, right ventricle, and left ventricular ejection fraction (EF) [15].
- Lung Pressures: An estimate of the PASP [10].
- Rhythm: Whether your heart was in a normal rhythm or atrial fibrillation during the test [1].
Common questions in this guide
What does an echocardiogram look for in rheumatic heart disease?
What does the mitral valve area number mean on an echo?
Why can my heart rate change the mean gradient?
Does a PASP above 40 mmHg confirm pulmonary hypertension?
Can a standard transthoracic echo rule out a blood clot?
What do ejection fraction and left atrial enlargement mean on my report?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the 'Wilkins score' or my valve anatomy, am I a candidate for a balloon procedure (PTMC) or will I likely need surgery?
- 2.Does my report show 'commissural fusion,' and how does that affect the choice of treatment for my mitral stenosis?
- 3.Is the pressure estimate in my lungs (PASP) elevated, and do we need a right-heart catheterization to confirm it?
- 4.How much does my heart rate during the echo affect the 'mean gradient' measurement on my report?
- 5.Will I need a Transesophageal Echo (TEE) down the throat to check for blood clots before we do any procedures?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography.
Pandian NG, Kim JK, Arias-Godinez JA, et al.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2023; (36(1)):3-28 doi:10.1016/j.echo.2022.10.009.
PMID: 36428195 - 2
Non-infectious thrombotic endocarditis associated with chronic rheumatic heart disease and disseminated tuberculosis.
Sekar A, Naganur S
Autopsy & case reports 2021; (11()):e2021269 doi:10.4322/acr.2021.269.
PMID: 34307226 - 3
Myocardial infarction due to septic thromboembolism in chronic rheumatic heart disease.
Rachagiri S, Sekar A, Mehrotra S, Saikia UN
Autopsy & case reports 2023; (13()):e2023444 doi:10.4322/acr.2023.444.
PMID: 37795254 - 4
Patterns of Rheumatic Heart Disease and Treatment Practices at Tertiary Care Center in Nepal: A Descriptive Cross-sectional Study.
Nepal R, Bista M, Dhungana SP
JNMA; journal of the Nepal Medical Association 2020; (58(230)):784-788 doi:10.31729/jnma.5405.
PMID: 34504361 - 5
Echocardiographic Parameters and Complication Profiles Among Adult Patients with Rheumatic Heart Disease at Jimma Medical Center.
Berhanu H, Mossie A, Morankar SN, et al.
Vascular health and risk management 2024; (20()):157-166 doi:10.2147/VHRM.S451957.
PMID: 38595828 - 6
Validation of Yeo's index in assessing severity of rheumatic mitral stenosis in mixed valve lesions.
Leow R, Li TY, Kong WKF, et al.
International journal of cardiology. Heart & vasculature 2024; (53()):101447 doi:10.1016/j.ijcha.2024.101447.
PMID: 38979528 - 7
The assessment of mitral valve disease: a guideline from the British Society of Echocardiography.
Robinson S, Ring L, Augustine DX, et al.
Echo research and practice 2021; (8(1)):G87-G136.
PMID: 34061768 - 8
Mitral Stenosis in the Multimodality Imaging Era: Pitfalls, Stress Echocardiography, and Integrated Therapeutic Assessment.
Pala B, Piscione M, Gaudio D, et al.
Diagnostics (Basel, Switzerland) 2026; (16(14)) doi:10.3390/diagnostics16142285.
PMID: 42510148 - 9
[Discordance between mitral valve area (MVA) and pressure gradient in patients with mitral valve stenosis: mean transmitral valve gradient is a severity index or a tolerance index of severity of mitralss valve stenosis?]
Najih H, Arous S, Laarje A, et al.
The Pan African medical journal 2016; (25()):75 doi:10.11604/pamj.2016.25.75.8797.
PMID: 28292038 - 10
Identification of Distinct Subgroups in Moderately Severe Rheumatic Mitral Stenosis Using Data-Driven Phenotyping of Longitudinal Hemodynamic Progression.
Ko KY, Cho I, Kim S, et al.
Journal of the American Heart Association 2022; (11(15)):e026375 doi:10.1161/JAHA.121.026375.
PMID: 35904199 - 11
Prevalence of pulmonary hypertension and associated factors among rheumatic heart disease patients in Ethiopia.
Gedefaw A, Ayele YY, Wudie G, et al.
BMC cardiovascular disorders 2025; (25(1)):20 doi:10.1186/s12872-025-04476-3.
PMID: 39810078 - 12
Trans-esophageal Echocardiographic Assessment of Left Atrial and Left Atrial Appendage Function in Atrial Fibrillation and Rheumatic Heart Disease.
Jain R, Aggarwal P, Jha MJ, et al.
Cureus 2021; (13(10)):e18653 doi:10.7759/cureus.18653.
PMID: 34790439 - 13
Rheumatic heart disease of the mitral valve alongside the papillary fibroelastoma of the aortic valve: A case report.
Khezerlouy Aghdam N, Delkhah M, Danayi S, Sobhi N
Clinical case reports 2024; (12(5)):e8845 doi:10.1002/ccr3.8845.
PMID: 38689685 - 14
Advances in Rheumatic Mitral Stenosis: Echocardiographic, Pathophysiologic, and Hemodynamic Considerations.
Silbiger JJ
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2021; (34(7)):709-722.e1 doi:10.1016/j.echo.2021.02.015.
PMID: 33652082 - 15
Rheumatic heart disease is not over: Cardiac cirrhosis and multivalvular sequelae in an endemic setting - A case series and review.
Sethi Y, Yadav ND, Singhal S, et al.
Current problems in cardiology 2026; (51(7)):103329 doi:10.1016/j.cpcardiol.2026.103329.
PMID: 41864251
This page is for informational purposes only and does not replace medical advice. It explains echocardiogram terms in rheumatic heart disease; ask your cardiologist to interpret your measurements, rhythm, and need for further testing.
Get notified when new evidence is published on rheumatic congestive heart failure.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.